37,393 shares of Myriad Genetics, Inc. (NASDAQ:MYGN) purchased by HRT Financial LP

Myriad genetics logo

HRT Financial LP acquired a new stake in Myriad Genetics, Inc. (NASDAQ: MYGN – Get Rating) in the fourth quarter, according to its latest Form 13F filed with the Securities and Exchange Commission. The institutional investor acquired 37,393 shares of the company, valued at approximately $542,000. Other institutional investors and hedge funds have also recently … Read more

Women have been urged to seek out alternative HRT drugs as pharmacists warn of shortages

Stocks of popular HRT pills like Utrogestan, pictured, are running low leading the government to implement the Severe Shortage Protocol which limits pharmacists to prescribing no more than two months worth of capsules

Women who are unable to get their usual hormone replacement therapy (HRT) due to shortage shouldn’t worry about switching to products that aren’t in short supply, top menopause doctors advised. Demand for a HRT drug, Utrogestan 100 mg, has doubled in the past 12 months and increased fivefold since March 2021, according to manufacturer Besins. … Read more